Results 221 to 230 of about 1,682,964 (357)
ABSTRACT Objective The optimal treatment for neurosarcoidosis myelitis is uncertain. We characterize incident neurosarcoidosis myelitis and assess treatment response by MRI and clinical scales. Methods Incident probable or definite neurosarcoidosis myelitis in adults was retrospectively identified from 13 academic medical centers.
Giovanna S. Manzano +39 more
wiley +1 more source
Minimally invasive autopsy as a useful tool for RNA extraction in molecular pathology of lung diseases. [PDF]
Batah SS, Fabro AT.
europepmc +1 more source
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas +18 more
wiley +1 more source
Exploring the Influence of Metabolic Changes in Fibrotic Lung Diseases. [PDF]
Kumari S +5 more
europepmc +1 more source
THE USE OF RADIOACTIVE CARBON DIOXIDE TO MEASURE REGIONAL BLOOD FLOW IN THE LUNGS OF PATIENTS WITH PULMONARY DISEASE [PDF]
John B. West +2 more
openalex +1 more source
Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
Dissecting the role of gut microbiota heterogeneity in the onset of chronic lung diseases. [PDF]
Lin Y, Zhang X, Zuo Z, Xiao Y.
europepmc +1 more source

